abrdn Life Sciences Investors

Ownership Transactions Reported by 24 Insiders

Symbol
HQL on NYSE
Location
1900 Market Street, Suite 200, Philadelphia, Pennsylvania

Insiders trading volume in the past year

abrdn Life Sciences Investors executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Saba Capital Management, L.P. 10%+ Owner $48.3M +$10.9M +29.1% Jun 26, 2024
Daniel R. Omstead President, Director $2.45M +$277K +12.8% Sep 25, 2023
Bill Maher Director $26.4K +$23.6K +841% Aug 23, 2024
Rose DiMartino Director $15.5K +$15.5K Jul 16, 2024
Kathleen Goetz Director $14.5K +$5.33K +58.4% Apr 9, 2024
Todd Reit Director $13.8K +$13.8K Jan 2, 2024
Rebecca Suzanne Nichols Director of Adviser $0 Jun 10, 2024
Stephen Bird Director Oct 27, 2023
Megan Kennedy Secretary and Vice President Oct 27, 2023
abrdn Inc. Adviser Oct 27, 2023
Sharon Ferrari Treasurer and CFO Oct 27, 2023
Alan R. Goodson Vice President Oct 27, 2023
Jennifer A. Nichols Director of Adviser Oct 27, 2023
Joseph Andolina Chief Compliance Officer & VP Oct 27, 2023
James O'Connor Director of Adviser Oct 27, 2023
Joshua Duitz Vice President Dec 13, 2023
Ben Ritchie Vice President Dec 13, 2023
Loretta Tse Vice President Mar 13, 2024
Marika Tooze Director of Adviser Oct 27, 2023
Michael Taggart Vice President Jun 12, 2024
Jaclyn Matsick Director of Adviser Oct 27, 2023
Christian Pittard President Oct 27, 2023
Lucia Sitar VP and Chief Legal Officer Oct 27, 2023
W. Mark Watson Director Jun 9, 2022

Recent Insider Transactions by Companies or Individuals for abrdn Life Sciences Investors

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.